Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers

SIMPLE SUMMARY: Aimed at minimizing side toxicities cancer therapies require appropriate functional vehicles at the nanoscale, for receptor-mediated tumor-targeted drug delivery. The aim of the present study was to explore the human peptide EPI-X4 as a CXCR4-targeting agent in self-assembled, protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Cano-Garrido, Olivia, Álamo, Patricia, Sánchez-García, Laura, Falgàs, Aïda, Sánchez-Chardi, Alejandro, Serna, Naroa, Parladé, Eloi, Unzueta, Ugutz, Roldán, Mònica, Voltà-Durán, Eric, Casanova, Isolda, Villaverde, Antonio, Mangues, Ramón, Vázquez, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230831/
https://www.ncbi.nlm.nih.gov/pubmed/34208189
http://dx.doi.org/10.3390/cancers13122929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230831/
https://www.ncbi.nlm.nih.gov/pubmed/34208189
http://dx.doi.org/10.3390/cancers13122929

Ejemplares similares